12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PLX cells: Phase I/II started

Pluristem began a double-blind, placebo-controlled, German Phase I/II trial to evaluate 2 doses of intramuscular injections of PLX cells into the lacerated gluteal muscle before suturing...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >